AuthorJason | Sales, Startup and Founder News
A curated index of the sales tools, experts, startups and partners we actually use and recommend.

Stop pitching harder. Start pitching sharper. Get the system founders use to close faster.
New? Start Here Or get the Future of Selling System →
Geneva and Boston-based Neurosterix has closed a $105 million Series B to advance its pipeline of allosteric modulator drugs targeting complex neuropsychiatric disorders — a field where patients have waited decades for meaningful new medicines.
Isomorphic Labs closed a $5 billion Series C on Nov 17, 2026. Here is what is confirmed, what is not, and what AI-bio founders should take from it.

San Diego biotech Seawolf Therapeutics emerged from stealth on November 16, 2026 with $100M in Series A financing and a multi-target deal with Sanofi worth up to $1.2B, built on its TRIDENT DNA delivery platform.

Galvanize Therapeutics has closed an oversubscribed $130 million Series D to scale its pulsed electric field surgical ablation platform for soft-tissue cancers, bringing a category of energy-based therapy toward broader clinical use.

How Richard Branson converted skeptics into early adopters by making them feel like pioneers. Founder early adopter scripts plus P.I.T.C.H. Formula. From $19/mo.

How Jeff Bezos built Amazon's credibility before having any track record. Founder credibility scripts plus P.I.T.C.H. Formula. From $19/mo.

How Mark Cuban disrupted pharma pricing and what every biotech founder can learn. Founder biotech pricing scripts plus P.I.T.C.H. Formula. From $19/mo.

How Bill Gates sells new tech to hospitals and health systems against institutional resistance. Founder health system scripts plus P.I.T.C.H. Formula. From $19/mo.